申请人:Laboratoire L. Lafon
公开号:US05446060A1
公开(公告)日:1995-08-29
The present invention relates to compounds of formula: ##STR1## in which A is selected from pyrrolidino, piperidino, morpholino, 1-imidazolyl, hexamethylenimino and 1-piperazinyl groups, these groups being unsubstituted or it being possible for them to contain 1 or 2 substituents selected from C.sub.1 -C.sub.3 alkyl and C.sub.1 -C.sub.3 hydroxyalkyl groups, and the addition salts of these compounds with pharmaceutically acceptable acids. These compounds are usable in therapy as peripheral vasodilators.
本发明涉及下式化合物:
其中A从吡咯烷基、哌哆啶基、吗啉基、1-咪唑基、己亚甲基胺基和1-哌嗪基中选择,这些基团未取代或可能包含1或2个选自C.sub.1-C.sub.3烷基和C.sub.1-C.sub.3羟基烷基的取代基,并且这些化合物与药用可接受酸的加合盐可作为外周血管扩张剂用于治疗。